BELOREN®

BELOREN®
Product Description

• Generic version of Skinoren/Finacea (Leo Pharma/Bayer)
• Molecule: Azelaic Acid • Market: L700 (ACNE VULGARIS) & L71 (ROSACEA) • Therapeutic Indications: Creme formulation indicated for mild to moderate acne vulgaris / gel formulation indicated for mild to moderate papular-pustular acne of the facial area & papulopustular rosacea 


• Formulations available: Gel, Cream 
 
• Skinoren off-patent: since 2017

DERMAGO

  • Country/Region:
    Germany
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Consultancy
Distributor/Import Export
Licensee
Pharmaceutical company
Wholesale/Retail
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Specifications
  • Details
    Application on the skin
  • Selling Points
    International Approvals/Standards
  • Model
    Licensing-and Supply
  • Supplied from
    Germany
  • Measured In
    gram

DERMAGO

  • Country/Region:
    Germany
  • On CPHI since:
    2022
  • Employees:
    1 - 24
Company types
Consultancy
Distributor/Import Export
Licensee
Pharmaceutical company
Wholesale/Retail
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)

More Products from DERMAGO (2)

  • SKINATAN®

    Product SKINATAN®

    • Generic version of Advantan®, Bayer • Molecule: Methylprednisolone Aceponate 0.1 % (4th generation Topical Glucocorticoids)

    • Market: D7A (Plain Topical Corticosteroids) •Therapeutic Indications: Dermatitis, Atopic Dermatitis, Contact Dermatitis (indication differs for...
  • VEREGEN®

    Product VEREGEN®

    • Innovative originator herbal product • Molecule: Sinecatechins (extract from green tea leaves) •Therapeutic Indications: External anogenital warts caused by Human Papilloma Virus (Type 6 and 11)

    • Formulation: Ointment •Global in-market sales 2020: ~€11m / ~1...